Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
The anti-tumour potential of Natural Killer Cells in prostate cancer
FY 2017-18
Summary
The immune system has the impressive ability to recognize and eliminate cancer cells. However, cancer cells often manage to evade the immune response, allowing for the development of a tumour. Recently, therapies that boost the anti-tumour activity of the immune system, referred to as immunotherapies, have generated spectacular results in certain types of cancer. These encouraging clinical results demonstrate the power of the immune system to prevent cancer.
In particular, prostate cancer manages to evade the immune response by undetermined mechanisms, and remains one of the most lethal cancers. One immune cell, the Natural Killer (NK) cell, has been shown to play an important role in the control and elimination of prostate cancer. However, NK cells eventually fail to eradicate this cancer, and it is not known why. I hypothesize that there are inhibitory interactions in the prostate tumour that suppress the ability of NK cells to kill cancer cells. I aim to reveal the nature of these inhibitory interactions, focusing on a class of proteins called checkpoint receptors. With this knowledge, I will develop immunotherapies that boost NK activity, allowing for an effective immune response against the tumour with therapeutic benefit.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
392070
Name
Hodgins Jonathan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The anti-tumour potential of Natural Killer Cells in prostate cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Immunology; Immunotherapy; Natural Killer Cells; Prostate Cancer
Abstract
The immune system has the impressive ability to recognize and eliminate cancer cells. However, cancer cells often manage to evade the immune response, allowing for the development of a tumour. Recently, therapies that boost the anti-tumour activity of the immune system, referred to as immunotherapies, have generated spectacular results in certain types of cancer. These encouraging clinical results demonstrate the power of the immune system to prevent cancer.
In particular, prostate cancer manages to evade the immune response by undetermined mechanisms, and remains one of the most lethal cancers. One immune cell, the Natural Killer (NK) cell, has been shown to play an important role in the control and elimination of prostate cancer. However, NK cells eventually fail to eradicate this cancer, and it is not known why. I hypothesize that there are inhibitory interactions in the prostate tumour that suppress the ability of NK cells to kill cancer cells. I aim to reveal the nature of these inhibitory interactions, focusing on a class of proteins called checkpoint receptors. With this knowledge, I will develop immunotherapies that boost NK activity, allowing for an effective immune response against the tumour with therapeutic benefit.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hodgins, Jonathan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~